Xencor is trading 5.29% up at $32.10 on November 4, 2026; broad-market gains may be supporting the move, but no new company-specific announcement clearly explains it. - Supplied context shows major indexes up more than 1%. - The latest XmAb819 trial update is earlier news, not a confirmed catalyst for this session. - Biotech sector strength was reported in the prior session; current XBI performance is not confirmed here.